(Q48267716)

10 February 2018

title

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study. (English)

1 reference

10 February 2018

magnetic resonance imaging

main subject

multiple sclerosis

0 references

0 references

2

Palace J

1 reference

10 February 2018

Lee MA

1

1 reference

10 February 2018

Stabler G

3

1 reference

10 February 2018

Ford J

4

1 reference

10 February 2018

Gearing A

5

1 reference

10 February 2018

Miller K

6

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 February 1999

1 reference

10 February 2018

published in

Brain

1 reference

10 February 2018

volume

122 ( Pt 2)

1 reference

10 February 2018

page(s)

191-197

1 reference

10 February 2018

The role of inflammation and cytokines in brain injury

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.2.191

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.2.191

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.2.191

Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.2.191

Structural biochemistry and activation of matrix metalloproteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.2.191

Relating matrix metalloproteinase structure to function: why the "hemopexin" domain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.2.191

Review: cytokines and the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.2.191

TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.2.191

Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.2.191

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.2.191

Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.2.191

Leukocyte Gelatinase B Cleavage Releases Encephalitogens from Human Myelin Basic Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.2.191

Processing of tumour necrosis factor-α precursor by metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.2.191

Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.2.191

Protease production by cultured microglia: substrate gel analysis and immobilized matrix degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.2.191

Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.2.191

21 January 2018

Identifiers

DOI

10.1093/BRAIN/122.2.191

1 reference

10 February 2018

release_53g3yqljaffmjakp5fq3pdeug4

Fatcat ID

0 references

PubMed ID

10071048

1 reference

10 February 2018